HomeHealth NewsBlocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests

Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests

May 27, 2026

- Advertisement -

Dr. Jezabel Rodriguez Blanco’s research looks at repurposing a drug that already has FDA approval and using it instead to address relapse in medulloblastoma. Credit: Clif Rhodes

For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are encouraging. But for a subset, remission is not the end of the story. Roughly 30% of patients will…

Click here to view the original article.

Tags
Medical Xpress

- Advertisment -

Qollateral Redefines Luxury Asset-Backed Lending for Collectors

Shivam Tewari Is Shaping the Future of Energy With Nuvora

Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests

Recently Viewed

NSW farmers confidence tanks as costs surge

Directed Technologies acquires Bangkok telematics provider GPS2GO to deepen South-East Asian push

Business travel hacks from the experts

Melbourne teen accused of attempted Jetstar hijacking faces higher court in alleged terrorism case

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

How much superannuation does the average 30-year-old have, and how to give it a boost

'The path is cleared': Mayor won't be re-running to give new blood a shot

Your Horoscope This Week: June 7 To 13

POPULAR CATEGORY

FOLLOW US

Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US